Senior insider sale
Chief Financial Officer at WHITEHAWK THERAPEUTICS, INC. — senior position signals high conviction
$6.6K
2.81K shares
What this filing means
GIACOBELLO SCOTT M. plans to sell 2.81K shares of WHITEHAWK THERAPEUTICS, INC. valued at approximately $6.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2025ACC: 0001786205-25-000023
Officer· Chief Financial Officer
Since Nov 2021
2.81K
Shares to sell
$6.6K
Approx. market value
6.75K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/1/2025
6.75KTotal acquired6.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Restricted Stock Units N/A | 6.75K | — |
| Total | 6.75K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.81K
Market value
$6.6K
3/3/2025
Total
Units
2.81K
Value
$6.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/3/2025 | 2.81K | $6.6K | NASDAQ | Planned |
| Total | 2.81K | $6.6K | ||